HOMEwww.epgonline.orgDRUGSwww.epgonline.orgDISEASE KNOWLEDGEwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgREGISTERwww.epgonline.orgSEARCH
Members
Why a doctor should
Username/Email

Password ()




EPG on Twitter EPG Online Twitter
EPG Online Blog EPG Online Blog
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Search
Languages

ALPHAPARIN overview
Prophylaxis of peri- and post- operative venous thromboembolism.

Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.

Change language Current language database: English
 
 
Related DrugsDrug Details
ALPHAPARIN
Drug Class Description :

Low molecular weight heparins (LMWHs, anticoagulants).

Generic Name :

Certoparin

Drug description :

Solution in pre-filled syringes.

Presentation :

Injection, certoparin 3000 i.u. anti-Factor Xa activity.

Indications :

Prophylaxis of peri- and post- operative venous thromboembolism.

Adult Dosage :

3000 i.u. daily by subcutaneous injection into the peritoneal fold 1 - 2 hours prior to surgery. Repeat once daily for 7 to 10 days or until mobile.

Child Dosage :

Not recommended.

Contra Indications :

Major bleeding disorders, bleeding ulcers of the stomach or intestine, severe hypertension (>200/120mmHg), hypersensitivity to heparin, subacute bacterial endocarditis, severe renal and/or hepatic dysfunction.

Special Precautions :

Must not be administered intramuscularly. Monitor platelet counts. May cause hyperkalaemia, particularly in diabetes mellitus, chronic renal failure, mellitus, chronic renal failure, pre-existing metabolic acidosis, patients with raised plasma potassium or taking potassium- sparing drugs; measure plasma potassium before starting therapy, and monitor regularly thereafter, especially if treatment prolonged beyond 7 days. Spinal or epidural anaesthesia - risk of spinal haematomas and paralysis; observe patients carefully. Pregnancy and lactation.

Interactions :

NSAIDs, oral anticoagulants, dipyridamole, dextrans, etacrynic acid (ethacrynic acid), cytostatic agents, antihistamines, digitalis, tetracyclines, ascorbic acid.

Adverse Reactions :

Minor bleeding at injection site, thrombocytopenia, hypersensitivity reactions, raised liver enzymes, osteoporosis. Rarely, clinically significant hyperkalaemia. Very rarely, spinal haematomas in patients undergoing spinal or epidural anaesthesia.

Manufacturer :

Grifols

Drug Availability :

(POM)

Drug Updated :

04 June 2009

Related Drugs - Anticoagulants, antithrombotics & fibrinolytics
Advancing Immunotherapy in Oncology The prognosis of patients with diabetes is improved by interventions that reduce HbA1C Alzheimer's disease (AD) is a progressive, neurodegenerative disease which will affect most of us at one point in time, and it’s prevalence increases with age. Ophthalmics - understanding, management, diagnosis and treatment information
New and updated Drugs
UK Drugs EPG Medical News Feed
Spanish Drugs EPG Medical News Feed
German Drugs EPG Medical News Feed
Norweigan Drugs EPG Medical News Feed
Netherlands Drugs EPG Medical News Feed
Swedish Drugs EPG Medical News Feed
French Drugs EPG French Drugs Feed
Portuguese Drugs EPG Portuguese Drugs Feed
Italian Drugs EPG Italian Drugs Feed

Atopic Dermatitis

Atopic Dermatitis

CONNECT

DISEASE CENTRES Disease Centres feed

AFFILIATE PARTNERS

QUICK SEARCH

GUIDELINES UK Drug Data Feed

DRUG DATA UK Drug Data Feed

REFERENCES